Prophylaxis

Displaying 21 - 30 of 49

Biomedical startup obtains CE mark for blood analysis platform

Biomedical startup obtains CE mark for blood analysis platform
Finnish biomedical startup Nightingale Health has announced CE marking for its blood biomarker analysis platform. The CE mark enables the clinical use of the analysis service and the analysed measures of creatinine and glucose in the EU region. Nightingale’s goal is to bring dozens of biomarkers included in the analysis platform gradually available for clinical use within the next year. The obtained CE mark is a step towards the company’s aim, enabling better prediction and targeted care for chronic diseases.
5th July 2017

Preparing the EU for the next pandemic

Preparing the EU for the next pandemic
  For 18 months, the PANDEM project has been preparing recommendations to help the EU face a potential pandemic. Armed with its planning tool and other project outcomes, the team has identified research priorities and innovations needed to strengthen preparedness for pandemics.
28th June 2017

Uncovering the best delivery mode for potential HIV vaccine

Uncovering the best delivery mode for potential HIV vaccine
For decades, HIV has successfully evaded all efforts to create an effective vaccine but researchers at The Scripps Research Institute (TSRI) and the La Jolla Institute for Allergy and Immunology (LJI) are steadily inching closer. Their latest study, published in the current issue of Immunity, demonstrates that optimising the mode and timing of vaccine delivery is crucial to inducing a protective immune response in a preclinical model.
21st June 2017


Chemists develop the ultimate natural sunscreen

Chemists develop the ultimate natural sunscreen
Chemists, materials scientists and nanoengineers at UC San Diego have created what may be the ultimate natural sunscreen. In a paper published in the American Chemical Society journal ACS Central Science, they report the development of nanoparticles that mimic the behavior of natural melanosomes, melanin-producing cell structures that protect our skin, eyes and other tissues from the harmful effects of ultraviolet radiation.
17th May 2017

Protein could increase effectiveness of vaccines

Protein could increase effectiveness of vaccines
Researchers have discovered a protein they believe would help make vaccinations more effective and provide protection from other diseases such as cancer. The findings, which appear online in Scientific Reports, allows for greater understanding of how vaccine enhancers work and can best be used. Researchers from Boston University School of Medicine (BUSM) purified a protein found on the exterior of bacteria (neisseria meningidis) and used it as an accessary to provide a better vaccination response.
7th April 2017

Pet exposure may prevent allergy and obesity

Pet exposure may prevent allergy and obesity
  If you need a reason to become a dog lover, how about their ability to help protect kids from allergies and obesity? A new University of Alberta study showed that babies from families with pets - 70% of which were dogs - showed higher levels of two types of microbes associated with lower risks of allergic disease and obesity.
7th April 2017

Mapping pathways to protective antibodies for HIV vaccine

Mapping pathways to protective antibodies for HIV vaccine
A Duke Health-led research team has described both the pathway of HIV protective antibody development and a synthetic HIV outer envelope mimic that has the potential to induce the antibodies with vaccination. "A goal for an HIV-1 vaccine is to induce broadly neutralising antibodies," said senior author Barton F. Haynes, M.D., director of the Duke Human Vaccine Institute (DHVI).
16th March 2017

Method produces leading anti-malarial drug

Method produces leading anti-malarial drug
  Researchers at Cardiff University have devised a new way of creating a drug commonly used as the first line of defence against malaria around the world. Artemisinin is a drug recommended by the World Health Organisation for treatment of all cases of severe malaria and works by attacking all stages of the malaria parasite in the blood.
15th March 2017

Oral delivery system could make vaccinations needle-free

Oral delivery system could make vaccinations needle-free
Patients could one day self-administer vaccines using a needleless, pill-sized technology that jet-releases a stream of vaccine inside the mouth, according to a proof-of-concept study conducted at UC Berkeley. The study did not test vaccine delivery in people, but demonstrated that the technology, called MucoJet, is capable of delivering vaccine-sized molecules to immune cells in the mouths of animals.
13th March 2017

Scaffolds covered in stem cells could prevent osteomyelitis

Scaffolds covered in stem cells could prevent osteomyelitis
Bone infections are often very difficult to treat, and with the rise of MRSA this issue has become only more challenging. A team of researchers from University of Missouri, University of North Carolina at Chapel Hill and North Carolina State University, and Silpakorn University in Thailand has developed a way of making tissue scaffolds that ward off MRSA while promoting natural healing at the site of their implantation.
27th February 2017


Prophylaxis documents


Sign up to view our publications

Sign up

Sign up to view our downloads

Sign up

POWER & ENERGY 2017
22nd November 2017
Rwanda Kigali
SPS IPC Drives 2017
28th November 2017
Germany Nuremberg
Cyber Security - Oil, Gas, Power 2017
29th November 2017
United Kingdom London
AI Tech World
29th November 2017
United Kingdom Olymipa, London
Maker Faire 2017
1st December 2017
Italy Rome